#Gene Editing

Total 1 articles

Visual representation of CRISPR base editing on DNA

Aurora Therapeutics CRISPR Rare Disease Strategy Leverages New FDA Pathway

Aurora Therapeutics, cofounded by Jennifer Doudna, is using a new FDA pathway to scale personalized CRISPR treatments for rare diseases like PKU. Discover the future of bespoke medicine.

Jan 9, 2026